Insider Transactions in Q2 2023 at Boston Scientific Corp (BSX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
6,697
-27.73%
|
$354,941
$53.8 P/Share
|
|
Jun 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-13.81%
|
$618,563
$53.24 P/Share
|
|
Jun 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.72%
|
$89,712
$14.7 P/Share
|
|
May 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
63,339
-22.85%
|
$3,356,967
$53.6 P/Share
|
|
May 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
56,921
+17.04%
|
$739,973
$13.08 P/Share
|
|
May 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-13.0%
|
$618,563
$53.49 P/Share
|
|
May 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.51%
|
$89,712
$14.7 P/Share
|
|
May 04
2023
|
Nelda J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+30.9%
|
-
|
|
May 04
2023
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+15.8%
|
-
|
|
May 04
2023
|
David J Roux Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+5.09%
|
-
|
|
May 04
2023
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+7.96%
|
-
|
|
May 04
2023
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+7.35%
|
-
|
|
May 04
2023
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,946
+9.73%
|
-
|
|
May 02
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Open market or private sale
|
Direct |
83,401
-87.18%
|
$4,336,852
$52.49 P/Share
|
|
May 02
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
30,688
+24.29%
|
$368,256
$12.89 P/Share
|
|
May 02
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
932
-3.72%
|
$48,464
$52.9 P/Share
|
|
May 02
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,101
+7.73%
|
-
|
|
May 02
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,917
-4.97%
|
$99,684
$52.9 P/Share
|
|
May 02
2023
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,203
+9.82%
|
-
|
|
Apr 17
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-12.28%
|
$595,221
$51.96 P/Share
|
|
Apr 17
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+3.31%
|
$89,712
$14.7 P/Share
|
|
Apr 05
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
4,903
-5.87%
|
$245,150
$50.4 P/Share
|
|
Apr 03
2023
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+0.13%
|
-
|